USPTO Codifies Director Review Rule in Landmark PTAB Decision Update Following Arthrex Ruling

Pieter Gunst01 mins

U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal has issued a final rule on the agency’s process for director review of certain Patent Trial and Appeal Board (PTAB) decisions. This move solidifies a mandate from the U.S. Supreme Court’s ruling in Arthrex three years ago. The finalization of this rule is a significant step in codifying the procedures for how the USPTO director can intervene in PTAB decisions. For more details on this development, visit the article on Law360.